Pharmaron Biologics and Cell & Gene Therapy

Pharmaceutical ManufacturingBeijing, China51-200 Employees

Pharmaron: Global Life Sciences Services Provider
Stock Code: 300759.SZ/3759.HK

Founded in 2004, Pharmaron is a leading life sciences service provider offering integrated Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) solutions across the biologics and cell and gene therapy (CGT) development spectrum - from discovery to market. With a global presence, advanced technologies, and regulatory expertise, we help partners accelerate timelines, reduce risks, and bring innovative therapies to patients faster.

Biologics and CGT Solutions
-----------------------------------------------
> Antibody Discovery and Protein Science – Supporting biologics programs from discovery to clinical development.
> Developability Assessment – Evaluating candidate molecules for manufacturability and therapeutic potential.
> Process Development – Optimizing and scaling upstream and downstream processes.
> Small-Scale Non-GMP and cGMP Manufacturing – Flexible production solutions for early development and clinical-scale needs.
> Analytical and Quality Control – Comprehensive testing to ensure product integrity and compliance.
> Regulatory Support – Guidance for global submissions, including IND and BLA filings.
> CGT Laboratory Services – In vitro assays, in vivo studies, biodistribution, and bioanalysis.
> Gene Therapy CDMO Services – Plasmid DNA manufacturing, viral vector development, and GMP manufacturing.

Connect with us to explore how Pharmaron can support your journey from discovery to market Biologics & Cell and Gene Therapy | Pharmaron

Keywords: CRO, CDMO, biologics development, CGT, antibody discovery, protein science, developability assessment, process development, cGMP manufacturing, analytical development, quality control, regulatory affairs, IND, BLA, cell and gene therapy (CGT)

Sign up for free to view info

Email Format Employee directory